Zobrazeno 1 - 10
of 1 589
pro vyhledávání: '"Pulmonary artery hypertension"'
Autor:
Dezhi Sun, Yangyi Hu, Yunming Li, Xianbiao Yu, Xi Chen, Pan Shen, Xianglin Tang, Yihao Wang, Chengcai Lai, Bo Kang, Zhijie Bai, Zhexin Ni, Ningning Wang, Rui Wang, Lina Guan, Wei Zhou, Yue Gao
Publikováno v:
Journal of Advanced Research, Vol 63, Iss , Pp 103-115 (2024)
Introduction:: Accurate identification of pulmonary arterial hypertension (PAH) in primary care and rural areas can be a challenging task. However, recent advancements in computer vision offer the potential for automated systems to detect PAH from ec
Externí odkaz:
https://doaj.org/article/b20b8a2d4b07460895e5920e7e1ae356
Autor:
Jiyoon Jung
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 973-981 (2024)
Introduction: Angioimmunoblastic T-cell lymphoma (AITL) is a rare form of non-Hodgkin lymphoma with diverse clinical presentations. This report describes a unique case of AITL presenting with pulmonary arterial hypertension (PAH), a rarely associated
Externí odkaz:
https://doaj.org/article/0ceed7b70f3b4351956d5c18d9a54bfc
Autor:
Junfei Li, Zengyu Zhang, Chenghui Zhu, Xiaorong Zheng, Chunlei Wang, Jianwei Jiang, Hongyan Zhang
Publikováno v:
European Journal of Medical Research, Vol 29, Iss 1, Pp 1-14 (2024)
Abstract Background Salidroside (SAL), derived from Rhodiola, shows protective effects in pulmonary arterial hypertension (PAH) models, but its mechanisms are not fully elucidated. Objectives Investigate the therapeutic effects and the mechanism of S
Externí odkaz:
https://doaj.org/article/1b3541c6005c44628b1211215587cbeb
Publikováno v:
ESC Heart Failure, Vol 11, Iss 2, Pp 619-627 (2024)
Abstract Pulmonary artery hypertension (PAH) is a chronic vascular disease defined by the elevation of pulmonary vascular resistance and mean pulmonary artery pressure, which arises due to pulmonary vascular remodelling. Prior research has already es
Externí odkaz:
https://doaj.org/article/f526e36570e34ead98a8072073a4c5f0
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
ObjectiveThis study strives to the variation and significance of microRNA-21 (miR-21) in children with congenital heart disease (CHD)-related pulmonary artery hypertension (PAH).MethodsChildren with CHD (n = 179) were selected as subjects, including
Externí odkaz:
https://doaj.org/article/9b35d1d7a0594c8984a1b6f10529dfcc
Publikováno v:
Pulmonary Circulation, Vol 14, Iss 2, Pp n/a-n/a (2024)
Abstract To explore the genetic causal association between pulmonary artery hypertension (PAH) and iron status through Mendelian randomization (MR), we conducted MR analysis using publicly available genome‐wide association study (GWAS) summary data
Externí odkaz:
https://doaj.org/article/8929cc7643f94f1a9e407f77861178d1
Autor:
Tracey Weiss, Dena R. Ramey, Ngan Pham, Nazneen Fatima Shaikh, Dajun Tian, Xiaohui Zhao, Aimee M. Near, Dominik Lautsch, Steven D. Nathan
Publikováno v:
Pulmonary Circulation, Vol 14, Iss 2, Pp n/a-n/a (2024)
Abstract This retrospective study was conducted to evaluate all‐cause healthcare resource utilization (HCRU) and costs in commercially insured patients living with pulmonary arterial hypertension (PAH) and explore end‐of‐life (EOL)‐related HC
Externí odkaz:
https://doaj.org/article/e1731666b6cb444782d67050c24c44a5
Publikováno v:
International Journal of Anatomy Radiology and Surgery, Vol 13, Iss 02, Pp 01-03 (2024)
Introduction: Acute pulmonary embolism is a life-threatening condition that can lead to sudden death. Pulmonary Artery Hypertension (PAH) can be found in the setting of acute pulmonary embolism. The Egg and Banana sign and Carina Crossover (CCO) sign
Externí odkaz:
https://doaj.org/article/57e7233b0d26455e982fb42f9b26ad1f
Publikováno v:
BMC Pulmonary Medicine, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Astragaloside (AS)-IV, extracted from traditional Chinese medicine Astragalus mongholicus, has been widely used in the anti-inflammatory treatment for cardiovascular disease. However, the mechanism by which AS-IV affects pulmonary
Externí odkaz:
https://doaj.org/article/867d7b69e8964bf69d23a90fe1052155
Autor:
Da-wei Lin, Zi-long Weng, Jia-ning Fan, Yu-liang Long, Li-hua Guan, Wen-zhi Pan, Da-xin Zhou, Jun-bo Ge
Publikováno v:
Reviews in Cardiovascular Medicine, Vol 25, Iss 8, p 307 (2024)
Background: In recent years, transcatheter aortic valve replacement (TAVR) has emerged as a pivotal treatment for pure native aortic regurgitation (PNAR). Given patients with severe aortic regurgitation (AR) are prone to suffer from pulmonary hyperte
Externí odkaz:
https://doaj.org/article/d1e8131cb2e748ff9eefb69e1a99e6fa